Lilly’s obesity pill helps reduce cardiovascular risks in late-stage trial
Eli Lilly Foundayo GLP-1 weight loss pill. Courtesy: Eli Lilly Eli Lilly said on Thursday its newly approved…
Novo Nordisk partners with OpenAI as AI drug discovery hopes mountÂ
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
Stitch Fix, apparel retailers may benefit
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
Tariffs and Iran war threaten India’s $100 billion garments export goal
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India”…
UK faces rising bills as new tax year starts
The headquarters of HM Revenue and Customs near the Houses of Parliament in the Westminster district of London,…
Trump tariffs fall, but trade war impacts linger
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
China Development Forum welcomes U.S. execs revamping market push
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the…
Restaurants add protein, fiber for weight loss drug users
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
What’s next for Novo Nordisk’s obesity drug CagriSema
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…